Ultime notizie per Immunovant (NASDAQ:IMVT) Azioni

Immunovant

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).

Immunovant Inc

This year's MJBizCon in Las Vegas promises to deliver crucial insights from industry pioneers, with two key panels featuring <a href="https://www.benzinga.com/cannabis">Benzinga Cannabis'</a> managing director <a href="https://www.benzinga.com/author/javier-hasse">Javier Hasse</a>, along with renowned voices in the cannabis sector. These sessions will provide actionable knowledge for entrepreneurs and investors navigating the burgeoning cannabis industry, including pivotal discussions on brand building and the rapid evolution of Latin American cannabis markets.
<h3 class="wp-block-heading">Embracing Your Brand's Unique Magic: How To Build An Iconic Brand In The Ancillary Market</h3>
Date &amp; Time: Wednesday, December 4, 2024, 2:00pm – 2:40pm Location: Room 2 &#8211; Cannabis Business 101
In this session, cannabis branding is the focal point, led by <a href="https://www.benzinga.com/markets/cannabis/24/08/40140453/how-a-simple-magic-trick-led-to-one-of-the-most-recognized-cannabis-related-brands-in-the-world-">Josh Kesselman</a>, CEO and founder of <a href="https://www.benzinga.com/markets/cannabis/24/07/40076950/raw-rolling-papers-are-not-drug-paraphernalia-court-confirms">RAW Rolling Papers</a>, a globally recognized brand rooted in authenticity and simplicity. Known for his unfiltered approach, Kesselman's journey—from opening a smoke shop to founding a major brand—demonstrates the power of authenticity in establishing a loyal customer base.
For those exploring opportunities in the cannabis ancillary market, Kesselman's insights will be invaluable. As he explains, the ancillary market remains a fertile ground for entrepreneurs free from stringent regulations that often accompany cannabis itself. Topics include unconventional marketing approaches and how to leverage technology and security to amplify brand presence. 
Javier Hasse's expertise in content and cannabis market growth adds an additional layer, with his experience shaping media narratives for both Benzinga and <a href="https://elplanteo.com/">El Planteo</a>. This panel invites entrepreneurs to think innovatively in a field where standing out is essential.
<h3 class="wp-block-heading">Cannabis In Latin America: Market Evolution And Opportunities</h3>
Date &amp; Time: Friday, December 6, 2024, 10:00am – 10:40am Location: Room N110 &#8211; International Regulatory Roundup
As cannabis markets continue to expand in Latin America, this panel explores the region's distinct landscape. Javier Hasse will join a discussion with industry leaders, including <a href="https://www.benzinga.com/markets/cannabis/24/06/39114436/how-3-chilean-brothers-built-a-global-cannabis-platform-embraced-by-big-sponsors-like-adidas-and">Simón Espinosa</a>, CEO of En Volá; Julian Wilches, co-founder and CRO at Clever Leaves (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLEVER#OTC">CLEVER</a>); and Zara Snapp, director at Instituto RIA. Together, they will dissect the evolving regulatory frameworks, investment potential and unique challenges in key countries such as Argentina, Mexico, Chile and Colombia.
This conversation will provide critical insights into how regulatory and social dynamics shape opportunities in Latin America, a region gaining prominence as both a cultivator and consumer of cannabis. Espinosa's experience with En Volá offers a cultural perspective, while Wilches and Snapp bring expertise in regulatory compliance and policy reform. Attendees will walk away with a nuanced understanding of how to navigate these diverse markets, the importance of local partnerships, and strategies for sustainable growth amid complex regulations.
More details <a href="https://mjbizconference.com/">here</a>.

Cannabis

News

Legal

Events

CLEVER

Josh Kesselman, Javier Hasse And More Experts Dive Into Cannabis Market Trends At MJBizCon

Donald Trump's 2024 presidential election win is already having an impact on<a href="https://www.benzinga.com/general/politics/24/11/41817245/will-trump-be-sentenced-in-hush-money-trial-or-will-his-criminal-problems-go-away"> his pending court cases</a>: a federal judge paused a 2020 election interference prosecution from Special Counsel Jack Smith Friday.
What Happened: Trump's defeat of Vice President Kamala Harris in <a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election">the 2024 presidential election</a> will put him back in the White House in January 2025. The election win could make it possible for Trump to avoid courtrooms in the future, with pending cases likely to be dismissed and thrown out.
On Friday, U.S. District Judge Tanya Chutkan paused a case against Trump related to election interference claims. Special Counsel Jack Smith previously charged Trump with trying to remain in the White House after the 2020 election despite losing to President Joe Biden.
Smith filed to pause the proceedings and said he plans to make a filing on Dec. 2 about how the criminal case should proceed now that Trump will be president again, as reported by <a href="https://www.bloomberg.com/news/articles/2024-11-08/us-special-counsel-asks-court-to-pause-trump-prosecution?srnd=homepage-americas&amp;sref=TBDibEcD">Bloomberg</a>.
Justice Department policy prevents the current president from being prosecuted, according to the report. Smith said the case will likely be dropped due to this policy.
On Friday, Smith said in a filing that he needs "time to assess this unprecedented circumstance and determine the appropriate course going forward" due to the Department of Justice policy.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent110824">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
What's Next: The 2020 election interference isn't the only case impacted by Trump's 2024 win.
Trump was previously found guilty on 34 counts of falsifying business records in what is known as the hush money trial. Sentencing in the case was delayed several times by Judge Juan Merchan and a sentencing date of Nov. 26 is now in question after Trump's election victory.
As <a href="https://www.benzinga.com/general/politics/24/11/41817245/will-trump-be-sentenced-in-hush-money-trial-or-will-his-criminal-problems-go-away">Benzinga reported Thursday</a>, legal experts are skeptical that Merchan would still carry out sentencing of the future sitting president. Merchan also plans to issue a ruling by Nov. 12 on Trump's legal team's request to toss out the guilty verdict after the Supreme Court issued partial immunity to former presidents earlier this year.
Trump faces potential punishment of up to four years in prison for each guilty verdict, with a limit of 20 total years in prison. While prison time is unlikely due to his lack of a previous criminal record, Trump could receive probation or home confinement.
If Merchan chooses to continue with sentencing he would be tasked with deciding whether to defer the sentencing to 2029 when Trump is out of the White House, delay Trump's punishment until 2029 or try to place the punishment on Trump while he's in office.
A classified documents case against Trump saw the former president charged in June 2023. The case, which was also brought against Trump by Smith, is also expected to be dismissed after the election result, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-11-08/can-trump-go-to-jail-after-2024-election-win-whats-next-in-his-criminal-cases?itm_source=record&amp;itm_campaign=Trump_Legal_Troubles&amp;itm_content=What%27s_Next-1&amp;sref=TBDibEcD">reported</a>.
A case against Trump in the state of Georgia saw charges brought against the former president in August 2023 related to conspiracy in the 2020 election. Trump's legal team is preparing for an argument to dismiss the case due to his return to the White House.
Among the reasons legal experts expect the cases to be dropped against Trump is a fear of retaliation against the judges and lawyers involved in cases.
On Thursday, Trump ally Mike Davis issued a warning to New York Attorney General Letitia James during an appearance on "The Benny Show" podcast.
"I dare you to try to continue your lawfare against President Trump in his second term," Davis said, as <a href="https://nypost.com/2024/11/07/us-news/trump-ally-mike-davis-warns-ny-ag-letitia-james-to-back-off-president-elect/">reported </a>by the New York Post. "Listen her, sweetheart, we're not messing around this time and we will put your fat a&#8211; in prison for conspiracy against rights. I promise you that."
James won a $454 million civil fraud judgment in the state of New York related to Trump and the Trump Organization's business dealings in the state. On Wednesday, James said she would "use the rule of law to fight back" against Trump. The president-elect has appealed the ruling in New York.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/social-media/24/11/41784933/donald-trumps-wealth-soars-with-2024-election-win-heres-how-much-president-elect-is-worth-ho">Donald Trump&#8217;s Wealth Soars With 2024 Election Win: Here&#8217;s How Much President-Elect Is Worth, How Much He&#8217;ll Make In White House</a></li>
</ul>
Photo via Shutterstock.

Politics

Trump 2020 Election Interference Case Paused: How 2024 Election Win Is Impacting President-Elect's Legal Troubles

Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) shares are trading higher Friday after climbing new highs during the week. Here&#8217;s what <a href="https://www.benzinga.com/quote/PLTR/news">you need to know.</a>
The Details: On Monday, Palantir <a href="https://www.benzinga.com/news/earnings/24/11/41730179/palantir-q3-earnings-revenue-beat-eps-beat-customers-up-39-raises-guidance-results-driven-by-unrele">reported third-quarter revenue</a> of $725.52 million, surpassing the $701.13 million estimate and earnings per share of 6 cents, beating expectations of 4 cents. Total revenue rose 30% year-over-year, with U.S. commercial revenue up 54% and U.S. government revenue up 40%. CEO Alex Karp added that the company's growth is "driven by unrelenting AI demand that won't slow down."
Shares<a href="https://www.benzinga.com/news/earnings/24/11/41746288/palantir-stock-is-hitting-new-highs-whats-going-on"> continued to rise </a>after some analysts commented on Palantir's expanding U.S. customer base and AI product demand. Analysts at Wedbush, Mizuho and DA Davidson all raised their price targets, with Wedbush's Dan Ives citing Palantir's "robust" results and AI expansion. 
The stock hit another all-time high on <a href="https://www.benzinga.com/news/earnings/24/11/41782430/palantir-shares-are-hitting-new-highs-on-wednesday-whats-going-on">Wednesday </a>after Donald Trump's presidential win sparked market optimism on potential policy shifts, which could favor defense and AI sectors. Palantir, up 25% over the past week, was seen as a potential beneficiary of a Trump administration&#8217;s defense and intelligence priorities.
Palantir shares also <a href="https://www.benzinga.com/news/24/11/41808861/whats-going-on-with-palantir-stock-thursday">faced early pressure</a> after Jefferies downgraded the stock from Hold to Underperform, citing valuation concerns. However, the stock bounced back intraday Thursday after Palantir announced a partnership with Amazon Web Services (AWS) and Anthropic to bring advanced AI capabilities to U.S. defense and intelligence agencies. The partnership will integrate Anthropic&#8217;s Claude AI models into Palantir's AI Platform for secure government use.
PLTR Price Action: Palantir shares were up 4.60% at $58.44 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="542" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08133801/PLTR-1024x542.png" alt="" class="wp-image-638322" style="width:469px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08133801/PLTR-1024x542.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08133801/PLTR-300x159.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08133801/PLTR-768x406.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08133801/PLTR.png 1180w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/41853996/sony-posts-upbeat-earnings-joins-tesla-upstart-doximity-fortrea-axon-enterprise-and-other-big-stocks-moving-higher-on-friday">Sony Posts Upbeat Earnings, Joins Tesla, Upstart, Doximity, Fortrea, Axon Enterprise And Other Big Stocks Moving Higher On Friday</a></li>
</ul>
Image Via Shutterstock.

Movers

PLTR

What's Going On With Palantir Stock This Week?

Throughout the last three months, 4 analysts have evaluated Dianthus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNTH#NASDAQ">DNTH</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Dianthus Therapeutics, revealing an average target of $46.0, a high estimate of $56.00, and a low estimate of $40.00. Marking an increase of 5.34%, the current average surpasses the previous average price target of $43.67. 
<img src="https://www.benzinga.com/files/images/story/2024/1731099673_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Dianthus Therapeutics among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steven Seedhouse</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$56.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Leland Gershell</td>
<td>Oppenheimer</td>
<td>Announces</td>
<td>Outperform</td>
<td>$48.00</td>
<td>-</td>
</tr>
<tr>
<td>Swayampakula Ramakanth</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Swayampakula Ramakanth</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Dianthus Therapeutics. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Dianthus Therapeutics compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Dianthus Therapeutics's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Dianthus Therapeutics's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/DNTH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Dianthus Therapeutics analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>All You Need to Know About Dianthus Therapeutics</h2>
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
<h3>Understanding the Numbers: Dianthus Therapeutics's Finances</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Dianthus Therapeutics's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 92.26%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -945.09%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Dianthus Therapeutics's ROE stands out, surpassing industry averages. With an impressive ROE of -4.82%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Dianthus Therapeutics's ROA stands out, surpassing industry averages. With an impressive ROA of -4.69%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.0, Dianthus Therapeutics adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

DNTH

A Glimpse Into The Expert Outlook On Dianthus Therapeutics Through 4 Analysts

Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) is reportedly considering the sale of Jeppesen, a navigation unit it acquired in 2000, to reduce its $58 billion debt. <a href="https://www.bloomberg.com/news/articles/2024-11-08/boeing-is-exploring-possible-6-billion-sale-for-jeppesen-unit?srnd=homepage-americas">Bloomberg reported </a>that the company is working with an adviser on a sale that could bring in more than $6 billion. 
The unit, which provides navigation tools to airlines, has already attracted interest from many private equity firms.
The possible divestment follows CEO Kelly Ortberg's review of Boeing's assets to identify units that may no longer align with the company&#8217;s focus on core commercial aircraft production. Ortberg said in an earnings call that he's looking at "whether a business or product fits with the long-term strategy or whether it would be better off someplace else."
Ortberg also confirmed that Boeing will pay employees furloughed during the seven-week strike in Seattle, according to a <a href="https://www.bnnbloomberg.ca/business/company-news/2024/11/08/boeing-ceo-says-furloughed-workers-will-be-paid-for-lost-time/#:~:text=%E2%80%9CAs%20we%20navigated%20through%20the,first%20weeks%20of%20his%20tenure.">BNN Bloomberg report.</a> "We want to acknowledge your support by returning your lost pay," the CEO said in an internal memo. 
However, the company plans more job cuts to reduce costs. Boeing has already been cutting costs with hiring freezes and corporate travel reductions to handle its cash shortage.
BA Price Action: Boeing shares were up 0.48% at $151.70 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="543" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08125901/BA-1-1024x543.png" alt="" class="wp-image-638240" style="width:624px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08125901/BA-1-1024x543.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08125901/BA-1-300x159.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08125901/BA-1-768x407.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08125901/BA-1.png 1185w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/legal/24/11/41853052/how-much-is-nintendo-suing-palworld-for-patents-financial-details-unveiled">How Much Is Nintendo Suing Palworld For? Patents, Financial Details Unveiled</a></li>
</ul>
Image Via Shutterstock.

What's Going On With Boeing Shares Today?

TVGN

Tevogen Bio Nears Finalization Of R&D And Manufacturing Expansion Deal With CD8 Technology; Secures $36M Line Of Credit To Support Operations And Long-Term Growth

Salesforce, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) shares are trading higher Friday. The company revealed plans to hire over 1,000 employees to support the sales push for its new AI product, Agentforce, which targets the growing demand for AI-driven automation across various business functions. Here&#8217;s <a href="https://www.benzinga.com/markets/equities/24/10/41607435/salesforce-launches-agentforce-redefining-ai-in-business-with-autonomous-solutions">what you need to know.</a>
What To Know: <a href="https://www.bloomberg.com/news/articles/2024-11-08/salesforce-to-hire-1-000-salespeople-for-ai-agent-push">According to Bloomberg</a>, Agentforce is designed to help companies set up AI agents capable of performing tasks like customer service, marketing and order management autonomously. The product integrates with Salesforce&#8217;s Customer 360 platform, making it part of the company's broader shift toward AI-powered business automation. Initial pricing for Agentforce is about $2 per agent conversation and Salesforce reports positive initial customer feedback.
CEO Marc Benioff described the hiring expansion as a response to "amazing momentum" for the generative AI tool, noting positive customer feedback since its launch two weeks ago.
In addition to these new hires, Salesforce's stock may have also gained momentum due to a "Golden Cross" technical signal, which indicates that its short-term (50-day) moving average has moved above its long-term (200-day) moving average.
Benioff commented on the move, highlighting the "incredible momentum" behind Agentforce and expressing confidence in the company's ability to capture new growth opportunities in AI. 
CRM Price Action: Salesforce shares were up 3.59% at $321.94 at the time of writing, according to Benzinga Pro.
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="547" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08151403/CRM-1024x547.png" alt="" class="wp-image-638463" style="width:420px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08151403/CRM-1024x547.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08151403/CRM-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08151403/CRM-768x410.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08151403/CRM.png 1131w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41856124/why-natures-miracle-nmhi-stock-is-down-28">Why Nature&#8217;s Miracle (NMHI) Stock Is Down 28%</a></li>
</ul>
Image Via Shutterstock.

Salesforce Shares Are Trading Higher Today: What You Need To Know

To gain an edge, this is what you need to know today.
<figure class="wp-block-image size-large is-resized"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2024/11/2024-11-08_08h12_07.png" alt="" style="width:624px" /></figure>
<h4 class="wp-block-heading">Nvidia As An Indicator</h4>
Please <a href="https://thearorareport.com/chart-analysis-stock-trump-hopium-nvidia-indicator-china-stimulus-nvda-mc-11082024">click here</a> for an enlarged chart of NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
Note the following:
<ul>
<li>This article is about the big picture, not an individual stock.&nbsp; The chart of NVDA stock is being used to illustrate the point.</li>
<li>The chart shows that NVDA has broken out.</li>
<li>RSI on the chart shows that NVDA has room to run.</li>
<li>Nvidia will report earnings on Nov. 20 after the market close.&nbsp; Historically, NVDA stocks sees heavy buying before earnings. As full disclosure, in addition to the core position in NVDA, which is long from $12.55, The Arora Report also has a trade around position in NVDA in The Arora Report&#8217;s ZYX Buy.</li>
<li>The chart shows the top support zone.&nbsp; This top support zone is very significant as an indicator for the entire market, not just NVDA stock.</li>
<li>For the time being, as a simple short cut, investors can use Nvidia as an indicator.&nbsp; As long as NVDA stock does not break below the top support zone, investors' stance towards the stock market should be bullish.&nbsp; The short cut is helpful but consider relying on the highly sophisticated, adaptive, <a href="https://thearorareport.com/ALLOCATION%2BMODELS.htm">ZYX Asset Allocation Model </a>with inputs in 10 categories.</li>
<li>The Arora Report call is to scale in by buying stocks and ETF's, not just NVDA, as they dip in the buy zones until a time when Trump hopium comes close to meeting reality.</li>
<li>In The Arora Report analysis, the time to take profits will be just before the Trump hopium comes close to meeting reality.&nbsp;&nbsp;</li>
<li>The stock market is moving based on the difference between Wall Street positioning going into the election and the election result.&nbsp; In The Arora Report analysis, the main cause of the rip roaring rally after the election is two-fold:
<ul>
<li>Wall Street was not positioned for the margin of Trump's victory.</li>
<li>Wall Street was not positioned for a potential red sweep.&nbsp; As of this writing, there is a high probability of a red sweep, but it is not yet confirmed.&nbsp; A red sweep will take place if Republicans take control of the House.</li>
</ul>
</li>
<li>Based on anecdotal evidence, it is difficult for many investors to put their arms around the current rally and The Arora Report's call to buy the dips.&nbsp; </li>
<li>In the early trade, the Trump rally is taking a breather for two reasons:
<ul>
<li>Investors' disappointment from China stimulus first impacted Asian markets, then moved to Europe, and now to the U.S.&nbsp; See the section below for details.</li>
<li>In the very very short term, the stock market is overbought.</li>
</ul>
</li>
<li>The University of Michigan Consumer Sentiment &#8211; Prelim will be released at 10am ET.&nbsp; It may be market moving.</li>
<li>In The Arora Report analysis, consumer sentiment has moved up significantly after Trump's election.&nbsp;&nbsp;&nbsp;</li>
</ul>
<h4 class="wp-block-heading">Big China Stimulus</h4>
China has announced a big stimulus of $1.4T.&nbsp; The stimulus will provide swaps for debt ridden local governments' off balance sheet liabilities.&nbsp; The size of the stimulus is greater than the consensus.&nbsp; For this reason, it should have been positive, but in The Arora Report analysis, investors are reacting negatively because the stimulus did not include any fiscal measures to boost the economy.&nbsp;&nbsp;
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are neutral in Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
In the early trade, money flows are negative in Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Alphabet Inc Class C (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and NVDA.
In the early trade, money flows are negative in SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.&nbsp; Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.&nbsp; The most popular ETF for gold is SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>).&nbsp; The most popular ETF for silver is iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>).&nbsp; The most popular ETF for oil is United States Oil ETF (ASCA:USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is being bought on hope that whales will take advantage of low liquidity during the weekend to run bitcoin up over $80,000.
<h4 class="wp-block-heading">Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.  The proprietary protection band from The Arora Report is very popular.  The protection band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Markets

ETFs

General

$BTC

AAPL

AMZN

GOOG

MSFT

NVDA

TSLA

Scale In On Trump Hopium Dips – Watch Nvidia As An Indicator, Big China Stimulus

GRFS

Mason Capital Criticizes Grifols Board For Governance Failures And Shareholder Value Loss; Calls For Independent Directors And Improved Oversight; Claims Brookfield Transaction Undervalues Grifols

AUTL

FDA Approves Obecabtagene Autoleucel (Aucatzyl) For Adults With Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia; 42% Achieved Complete Remission Within 3 Months

Asset Sales

Reuters Reported Boeing Close To Funding Agreement To Help Supplier Spirit Aerosystems That Could Be Announced In Next Few Days; Spirit Weighing Sale Of Defense Composites Supplier FMI

High-rolling investors have positioned themselves bullish on Oklo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in OKLO often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 30 options trades for Oklo. This is not a typical pattern.
The sentiment among these major traders is split, with 50% bullish and 36% bearish. Among all the options we identified, there was one put, amounting to $112,500, and 29 calls, totaling $2,339,238.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $2.5 to $40.0 for Oklo over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Oklo's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Oklo's substantial trades, within a strike price spectrum from $2.5 to $40.0 over the preceding 30 days.
<h3>Oklo Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731098929_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$5.2</td>
<td>$5.0</td>
<td>$5.1</td>
<td>$25.00</td>
<td>$510.0K</td>
<td>3.1K</td>
<td>1.2K</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$7.5</td>
<td>$7.1</td>
<td>$7.5</td>
<td>$26.00</td>
<td>$374.2K</td>
<td>47</td>
<td>520</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$3.6</td>
<td>$3.3</td>
<td>$3.45</td>
<td>$40.00</td>
<td>$176.6K</td>
<td>1.1K</td>
<td>610</td>
</tr>
<tr>
<td>OKLO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/22/24</td>
<td>$2.4</td>
<td>$2.25</td>
<td>$2.25</td>
<td>$24.00</td>
<td>$112.5K</td>
<td>49</td>
<td>506</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$6.2</td>
<td>$5.1</td>
<td>$5.4</td>
<td>$21.00</td>
<td>$94.5K</td>
<td>940</td>
<td>177</td>
</tr>
</tbody>
</table>

<h3>About Oklo</h3>
Oklo Inc is developing advanced fission power plants to provide clean, reliable, and affordable energy at scale. It is pursuing two complementary tracks to address this demand: providing reliable, commercial-scale energy to customers; and selling used nuclear fuel recycling services to the U.S. market. The Company plans to commercialize its liquid metal fast reactor technology with the Aurora powerhouse product line. The first commercial Aurora powerhouse is designed to produce up to 15 megawatts of electricity (MWe) on both recycled nuclear fuel and fresh fuel.
<h3>Current Position of Oklo</h3>
<ul>
<li>Trading volume stands at 18,810,980, with OKLO's price down by -1.51%, positioned at $26.16.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 6 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Oklo options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

OKLO

Check Out What Whales Are Doing With OKLO

Financial giants have made a conspicuous bearish move on Super Micro Computer. Our analysis of options history for Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) revealed 39 unusual trades.
Delving into the details, we found 43% of traders were bullish, while 51% showed bearish tendencies. Out of all the trades we spotted, 23 were puts, with a value of $1,781,693, and 16 were calls, valued at $804,721.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $13.0 and $87.0 for Super Micro Computer, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Super Micro Computer's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Super Micro Computer's significant trades, within a strike price range of $13.0 to $87.0, over the past month.
<h3>Super Micro Computer 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731098924_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SMCI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$12.3</td>
<td>$12.25</td>
<td>$12.27</td>
<td>$33.00</td>
<td>$576.5K</td>
<td>2.1K</td>
<td>753</td>
</tr>
<tr>
<td>SMCI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$13.55</td>
<td>$13.5</td>
<td>$13.5</td>
<td>$38.00</td>
<td>$135.0K</td>
<td>5.0K</td>
<td>115</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$6.65</td>
<td>$6.6</td>
<td>$6.65</td>
<td>$24.00</td>
<td>$129.0K</td>
<td>100</td>
<td>350</td>
</tr>
<tr>
<td>SMCI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/08/24</td>
<td>$0.58</td>
<td>$0.54</td>
<td>$0.61</td>
<td>$25.00</td>
<td>$88.8K</td>
<td>9.9K</td>
<td>6.2K</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$17.85</td>
<td>$17.7</td>
<td>$17.7</td>
<td>$13.00</td>
<td>$88.5K</td>
<td>512</td>
<td>72</td>
</tr>
</tbody>
</table>

<h3>About Super Micro Computer</h3>
Super Micro Computer Inc provides high-performance server technology services to cloud computing, data center, Big Data, high-performance computing, and "Internet of Things" embedded markets. Its solutions include server, storage, blade and workstations to full racks, networking devices, and server management software. The firm follows a modular architectural approach, which provides flexibility to deliver customized solutions. The Company operates in one operating segment that develops and provides high-performance server solutions based upon an innovative, modular and open-standard architecture. More than half of the firm's revenue is generated in the United States, with the rest coming from Europe, Asia, and other regions.
After a thorough review of the options trading surrounding Super Micro Computer, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Super Micro Computer's Current Market Status</h3>
<ul>
<li>With a volume of 53,554,019, the price of SMCI is down -3.89% at $24.49. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 17 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Super Micro Computer options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

SMCI

What the Options Market Tells Us About Super Micro Computer

Deep-pocketed investors have adopted a bearish approach towards Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in FICO usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 14 extraordinary options activities for Fair Isaac. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 42% leaning bullish and 50% bearish. Among these notable options, 2 are puts, totaling $71,378, and 12 are calls, amounting to $737,063.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $1700.0 to $2500.0 for Fair Isaac over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Fair Isaac options trades today is 16.6 with a total volume of 51.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Fair Isaac's big money trades within a strike price range of $1700.0 to $2500.0 over the last 30 days.
<h3>Fair Isaac Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731098919_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>FICO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$352.1</td>
<td>$352.0</td>
<td>$352.1</td>
<td>$2000.00</td>
<td>$352.0K</td>
<td align="right">29</td>
<td align="right">10</td>
</tr>
<tr>
<td>FICO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$375.6</td>
<td>$373.0</td>
<td>$375.6</td>
<td>$2000.00</td>
<td>$75.1K</td>
<td align="right">29</td>
<td align="right">12</td>
</tr>
<tr>
<td>FICO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$548.0</td>
<td>$538.0</td>
<td>$539.0</td>
<td>$1700.00</td>
<td>$53.9K</td>
<td align="right">4</td>
<td align="right">1</td>
</tr>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$55.6</td>
<td>$51.7</td>
<td>$55.6</td>
<td>$2200.00</td>
<td>$44.4K</td>
<td align="right">1</td>
<td align="right">8</td>
</tr>
<tr>
<td>FICO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$160.0</td>
<td>$155.1</td>
<td>$160.0</td>
<td>$2180.00</td>
<td>$32.0K</td>
<td align="right">3</td>
<td align="right">4</td>
</tr>
</tbody>
</table>

<h3>About Fair Isaac</h3>
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
Having examined the options trading patterns of Fair Isaac, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Fair Isaac Standing Right Now?</h3>
<ul>
<li>With a volume of 196,525, the price of FICO is down 0.0% at $2176.1. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 76 days.</li>
</ul>
<h3>Expert Opinions on Fair Isaac</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $2252.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Baird has decided to maintain their Neutral rating on Fair Isaac, which currently sits at a price target of $2000. 
&#x2A; In a cautious move, an analyst from RBC Capital downgraded its rating to Sector Perform, setting a price target of $2040. 
&#x2A; An analyst from Needham has decided to maintain their Buy rating on Fair Isaac, which currently sits at a price target of $2500. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on Fair Isaac, which currently sits at a price target of $2374. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Fair Isaac, which currently sits at a price target of $2350. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Fair Isaac with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

FICO

Looking At Fair Isaac's Recent Unusual Options Activity

SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) reported worse-than-expected third-quarter results on Wednesday and analysts are weighing in on what is <a href="https://www.benzinga.com/news/earnings/24/11/41806208/solaredges-tough-q3-revenue-miss-multi-billion-impairment-bleak-forecast-more">next for the company. </a>
Truist on SEDG: Truist analyst Jordan Levy highlighted prior commentary from Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) on weakness in the European market as forewarning for SolarEdge's disappointing results and guidance. 
SolarEdge expects revenue of between $180 million and $200 million for the fourth quarter, below the consensus of $308.66 million. 
Levy said market weakness is cyclical and sees SolarEdge as a "show-me story" over the coming quarters.&nbsp;
Truist reiterated its Hold rating on SolarEdge and lowered its price target from $20 to $15.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/24/11/41781921/what-does-trumps-victory-mean-for-ev-giant-tesla-and-the-big-3-automakers">What Does Trump&#8217;s Victory Mean For EV Giant Tesla And The Big 3 Automakers?</a>
BMO on SEDG: BMO Capital Markets analyst Ameet Thakkar pointed to Solar Edge's "disappointing update" and "meaningfully" lowered the price target on the stock from $21 to $12 as the European market "has gone from bad to worse."&nbsp;
The BMO analyst maintained a Market Perform rating and said SolarEdge should see growth alongside solar demand.&nbsp;
However, Thakkar said the company's management leaves him cautious and he would like to see "more urgency" in the rate of change to the company's cost structure and operational expenditures.&nbsp;
"At this point, given the already over 80% ytd decline in company share price, high short interest, and SEDG belatedly taking more decisive actions to clear its product channel in Europe we await to see if any progress emerges," the BMO analyst wrote.
SEDG Price Action: According to data from Benzinga Pro, SolarEdge Technologies shares are down 9.74% at $13.43 at the time of publication Friday.&nbsp;
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction">Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</a></li>
</ul>
Image: Shutterstock

Analyst Color

ENPH

SEDG

SolarEdge Is A 'Show-Me Story' After Disappointing Q3: Analyst

Whales with a lot of money to spend have taken a noticeably bearish stance on Expedia Group.
Looking at options history for Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) we detected 32 trades.
If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish expectations and 53% with bearish.
From the overall spotted trades, 16 are puts, for a total amount of $1,361,552 and 16, calls, for a total amount of $954,831.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $100.0 to $200.0 for Expedia Group during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Expedia Group's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Expedia Group's substantial trades, within a strike price spectrum from $100.0 to $200.0 over the preceding 30 days.
<h3>Expedia Group Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731098710_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>EXPE</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$11.35</td>
<td>$9.1</td>
<td>$10.4</td>
<td>$150.00</td>
<td>$520.0K</td>
<td align="right">45</td>
<td align="right">0</td>
</tr>
<tr>
<td>EXPE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/08/24</td>
<td>$47.95</td>
<td>$45.7</td>
<td>$45.7</td>
<td>$140.00</td>
<td>$182.8K</td>
<td align="right">93</td>
<td align="right">40</td>
</tr>
<tr>
<td>EXPE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$13.0</td>
<td>$11.7</td>
<td>$12.8</td>
<td>$185.00</td>
<td>$95.5K</td>
<td align="right">4</td>
<td align="right">76</td>
</tr>
<tr>
<td>EXPE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/22/24</td>
<td>$39.75</td>
<td>$38.75</td>
<td>$38.75</td>
<td>$150.00</td>
<td>$93.0K</td>
<td align="right">38</td>
<td align="right">33</td>
</tr>
<tr>
<td>EXPE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$17.7</td>
<td>$15.9</td>
<td>$17.7</td>
<td>$200.00</td>
<td>$88.5K</td>
<td align="right">59</td>
<td align="right">60</td>
</tr>
</tbody>
</table>

<h3>About Expedia Group</h3>
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2023 sales), air tickets (3%), rental cars, cruises, in-destination, and other (11%), and advertising revenue (6%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
After a thorough review of the options trading surrounding Expedia Group, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Expedia Group's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 3,695,283, the EXPE's price is up by 3.48%, now at $180.19. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 90 days.</li>
</ul>
<h3>What The Experts Say On Expedia Group</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $182.4.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on Expedia Group with a target price of $210. 
&#x2A; An analyst from B of A Securities has decided to maintain their Neutral rating on Expedia Group, which currently sits at a price target of $166. 
&#x2A; An analyst from UBS has decided to maintain their Neutral rating on Expedia Group, which currently sits at a price target of $156. 
&#x2A; Maintaining their stance, an analyst from Wedbush continues to hold a Neutral rating for Expedia Group, targeting a price of $180. 
&#x2A; Maintaining their stance, an analyst from BTIG continues to hold a Buy rating for Expedia Group, targeting a price of $200. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Expedia Group options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

EXPE

Unpacking the Latest Options Trading Trends in Expedia Group

Financial giants have made a conspicuous bullish move on Oracle. Our analysis of options history for Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) revealed 35 unusual trades.
Delving into the details, we found 62% of traders were bullish, while 22% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $292,307, and 30 were calls, valued at $3,141,583.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $240.0 for Oracle, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Oracle options trades today is 1815.6 with a total volume of 21,239.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Oracle's big money trades within a strike price range of $100.0 to $240.0 over the last 30 days.
<h3>Oracle Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731098705_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$12.5</td>
<td>$12.45</td>
<td>$12.5</td>
<td>$185.00</td>
<td>$672.6K</td>
<td>8.2K</td>
<td>2.3K</td>
</tr>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$13.95</td>
<td>$13.7</td>
<td>$13.78</td>
<td>$185.00</td>
<td>$452.7K</td>
<td>4.1K</td>
<td>335</td>
</tr>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$3.7</td>
<td>$3.6</td>
<td>$3.7</td>
<td>$187.50</td>
<td>$368.1K</td>
<td>2.9K</td>
<td>1.2K</td>
</tr>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$38.25</td>
<td>$38.25</td>
<td>$38.25</td>
<td>$170.00</td>
<td>$351.9K</td>
<td>1.0K</td>
<td>92</td>
</tr>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$1.43</td>
<td>$1.4</td>
<td>$1.4</td>
<td>$192.50</td>
<td>$210.0K</td>
<td>183</td>
<td>1.6K</td>
</tr>
</tbody>
</table>

<h3>About Oracle</h3>
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Following our analysis of the options activities associated with Oracle, we pivot to a closer look at the company's own performance.
<h3>Where Is Oracle Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 5,537,782, the ORCL's price is up by 1.76%, now at $189.65. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 31 days.</li>
</ul>
<h3>Expert Opinions on Oracle</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $185.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from RBC Capital lowers its rating to Sector Perform with a new price target of $165. 
&#x2A; An analyst from JMP Securities has decided to maintain their Market Outperform rating on Oracle, which currently sits at a price target of $205. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Oracle options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

ORCL

Unpacking the Latest Options Trading Trends in Oracle

Financial giants have made a conspicuous bullish move on Netflix. Our analysis of options history for Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) revealed 93 unusual trades.
Delving into the details, we found 37% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we spotted, 10 were puts, with a value of $516,789, and 83 were calls, valued at $6,209,128.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $10.0 to $1110.0 for Netflix over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Netflix's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Netflix's substantial trades, within a strike price spectrum from $10.0 to $1110.0 over the preceding 30 days.
<h3>Netflix Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731098699_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$786.8</td>
<td>$779.0</td>
<td>$782.88</td>
<td>$10.00</td>
<td>$234.8K</td>
<td>46</td>
<td align="right">44</td>
</tr>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$786.6</td>
<td>$779.0</td>
<td>$782.68</td>
<td>$10.00</td>
<td>$234.8K</td>
<td>46</td>
<td align="right">38</td>
</tr>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$786.7</td>
<td>$779.0</td>
<td>$782.83</td>
<td>$10.00</td>
<td>$156.5K</td>
<td>46</td>
<td align="right">46</td>
</tr>
<tr>
<td>NFLX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$170.25</td>
<td>$169.35</td>
<td>$170.25</td>
<td>$945.00</td>
<td>$153.1K</td>
<td>18</td>
<td align="right">14</td>
</tr>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/08/24</td>
<td>$4.1</td>
<td>$3.15</td>
<td>$3.86</td>
<td>$790.00</td>
<td>$138.6K</td>
<td>1.0K</td>
<td align="right">820</td>
</tr>
</tbody>
</table>

<h3>About Netflix</h3>
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 280 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm recently began introducing ad-supported subscription plans, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
Following our analysis of the options activities associated with Netflix, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Netflix</h3>
<ul>
<li>With a trading volume of 1,222,818, the price of NFLX is down by -0.41%, reaching $793.29.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 74 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Netflix</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $764.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Keybanc has decided to maintain their Overweight rating on Netflix, which currently sits at a price target of $785. 
&#x2A; Maintaining their stance, an analyst from Canaccord Genuity continues to hold a Hold rating for Netflix, targeting a price of $760. 
&#x2A; Consistent in their evaluation, an analyst from Rosenblatt keeps a Neutral rating on Netflix with a target price of $680. 
&#x2A; Maintaining their stance, an analyst from Needham continues to hold a Buy rating for Netflix, targeting a price of $800. 
&#x2A; An analyst from Macquarie persists with their Outperform rating on Netflix, maintaining a target price of $795. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Netflix options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

NFLX

Spotlight on Netflix: Analyzing the Surge in Options Activity

Cryptocurrency markets are trading mostly sideways to close out the week.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td> $76,596.76</td>
<td>-0.1%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td> $2,941.75</td>
<td>+1.8%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td> $198.79</td>
<td>+0.9%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td> $0.1959</td>
<td>+1.8%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td> $0.00001878</td>
<td>-0.9%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume decreasing by 26.3% and daily active addresses falling by 10.2%. Transactions greater than $100,000 are up from 15,034 to 11,544 in a single day. Exchanges netflows are up by 94.2%.</li>
<li>Coinglass data reports 91,985 traders were liquidated in the past 24 hours for $265.50 million.</li>
<li>On-chain and macro research provider Axel Adler Jr noted that the Bitcoin Profitability Index is currently at 221%, with past cycle peaks reaching 460% and 395%, and the previous high at 272%. Currently, <a href="https://x.com/AxelAdlerJr/status/1854795174192284140">users</a> have an average profitability exceeding their initial investments by 121%.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41851865/bitcoin-to-200000-ethereum-to-10000-and-crypto-market-cap-to-4x-by-end-of-2025-says-standard-chartered">Bitcoin To $200,000, Ethereum To $10,000 And Crypto Market Cap To 4X By End Of 2025, Says Standard Chartered</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41847581/el-salvadors-bitcoin-bet-is-paying-off-heres-how-much-the-country-is-up">El Salvador&#8217;s Bitcoin Bet Is Paying Off—Here&#8217;s How Much The Country Is Up</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41849213/crypto-queen-ruja-ignatova-onecoins-4-billion-fraud-mastermind-is-alive-and-in-south-africa-german-police-suspects">&#8216;Crypto Queen&#8217; Ruja Ignatova, OneCoin&#8217;s $4 Billion Fraud Mastermind, Is Alive And In South Africa, German Police Suspects</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41853924/cardano-up-13-as-speculation-around-charles-hoskinson-as-trump-crypto-policy-advisor-bubbles">Cardano Up 13% As Speculation Around Charles Hoskinson As Trump Crypto Policy Advisor Bubbles</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41841882/sol-staking-yields-double-ethereums-as-both-battle-treasury-rates">Solana Staking Yields Double Ethereum&#8217;s As Both Battle Treasury Rates</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41843928/bitcoin-etfs-saw-record-1-38-billion-inflows-on-thursday">Bitcoin ETFs Saw Record $1.38 Billion Inflows On Thursday</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Cronos (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">CRO</a>)</td>
<td>&nbsp;$0.1125</td>
<td>+22%</td>
</tr>
<tr>
<td>Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/matic/usd">MATIC</a>)</td>
<td>&nbsp;$0.4</td>
<td>+16.4%</td>
</tr>
<tr>
<td>Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>)</td>
<td> $0.44</td>
<td>+10.6%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With Bitcoin prices breaching the $76,000 mark, crypto trader Kevin sees BTC trading in an ascending triangle. He <a href="https://x.com/Kev_Capital_TA/status/1854946716887491071">says</a> the price target is $80,000.
Titan Of Crypto stated that Bitcoin "usually tops 12-13 months&#8221; after a U.S. presidential election. He predicts a potential cycle peak around the end of 2025, with a target of $150,000.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> Cycle Top Timing &#x1f30b; With the US election now behind us, <a href="https://twitter.com/hashtag/BTC?src=hash&amp;ref_src=twsrc%5Etfw">#BTC</a> usually tops 12-13 months later. This suggests a potential cycle peak around the end of 2025. Target: $150k+ &#x1f4c8; <a href="https://t.co/tQyljuAYVm">pic.twitter.com/tQyljuAYVm</a>
&mdash; Titan of Crypto (@Washigorira) <a href="https://twitter.com/Washigorira/status/1854917711559618980?ref_src=twsrc%5Etfw">November 8, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader More Crypto Online is optimistic about Bitcoin reaching at least $78,000 but <a href="https://x.com/Morecryptoonl/status/1854895285597589861">notes</a> that a drop below $74,500 would shift attention to a Fibonacci support zone between $69,418 and $73,977. For now, the local trend remains upward.
Javon Marks predicts Bitcoin could see a 51% rally to $116,652 if it holds the key $67,559 target. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">As prices of <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> (BTC) now hold well above a key $67,559 target, the next level in sight to be pushed is $116,652 in another +51% rally which can take place at a more powerful pace than many think! Next level can be incoming&#8230; <a href="https://t.co/NENUNz5jVx">https://t.co/NENUNz5jVx</a> <a href="https://t.co/flN9pJhJ8k">pic.twitter.com/flN9pJhJ8k</a>
&mdash; JAVON&#x26a1;&#xFE0F;MARKS (@JavonTM1) <a href="https://twitter.com/JavonTM1/status/1854887601104134465?ref_src=twsrc%5Etfw">November 8, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41841793/bitcoin-ethereum-solana-rally-does-not-mean-all-cryptocurrencies-will-moon-10x-research">Bitcoin, Ethereum, Solana Rally Does Not Mean All Cryptocurrencies Will Moon: 10x Research</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ADA

$CRO

$DOGE

$ETH

$MATIC

$POL

$SHIB

$SOL

Bitcoin, Ethereum, Dogecoin Close The Week Trading Sideways

Elon Musk&#8216;s fortune skyrocketed past $300 billion on Friday, fueled by a sharp rally in Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)'s stock after Donald Trump's election as <a href="https://www.benzinga.com/markets/equities/24/11/41813356/elon-musks-net-worth-soars-by-26-5-billion-in-single-day-after-tesla-stock-surges-post-trump-vic">the 47th U.S. president.</a>
According to Forbes&#8217; Real-Time Billionaires List, Musk&#8217;s net worth reached $305 billion — distantly followed by Oracle Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NASDAQ">ORCL</a>) co-founder Larry Ellison at around $231 billion, and Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)'s Jeff Bezos, who trails at approximately $225 billion.
Musk is now more than $100 billion richer than Meta Platform Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) CEO Mark Zuckerberg.
The electric carmaker's shares rocketed nearly 30% over the week, driving the company's market capitalization beyond the $1 trillion mark and delivering Musk a massive windfall.
Other than deriving much of his wealth from Tesla, Musk has also diversified his fortune in SpaceX, founded in 2002, which is worth nearly $210 billion based on a tender offer launched during the second half of 2024. Musk owns an estimated 42% stake.
Musk bought Twitter in a $44 billion (enterprise value) deal in 2022, although Forbes estimates that the social media company, which he renamed X, is worth nearly 70% less <a href="https://www.benzinga.com/top-stories/24/10/41603930/trump-vs-musk-djt-stock-worth-more-than-latest-x-valuation-thanks-to-2024-election-run-up">as of August 2024</a>.
Musk owns an estimated 60% of xAI, which he founded in 2023. Private investors valued the company at $24 billion in May 2024.
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>RANK</th>
<th>NAME</th>
<th>NET WORTH</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>Elon Musk </td>
<td>$305.5 billion</td>
</tr>
<tr>
<td>2</td>
<td>Larry Ellison </td>
<td>$230.9 billion</td>
</tr>
<tr>
<td>3</td>
<td>Jeff Bezos </td>
<td>$225.5 billion</td>
</tr>
<tr>
<td>4</td>
<td>Mark Zuckerberg </td>
<td>$203.4 billion</td>
</tr>
<tr>
<td>5</td>
<td>Bernard Arnault &amp; Family</td>
<td>$165.6 billion</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Source: Forbes Real-Time Billionaires List</figcaption></figure>
<h3 class="wp-block-heading">Why Trump's Victory Was A Big Win For Musk</h3>
Trump's stance on tariffs, specifically on vehicles imported from Europe and China, could potentially make it tougher for foreign carmakers to compete in the U.S. market — an advantage that could drive up Tesla's market share on its home turf.
A Trump presidency would likely mean the end of EV subsidies and tax credits during Tesla&#8217;s second-quarter earnings call.
The impact would be slight for Tesla and devastating for its competitors. &#8220;But long term probably actually helps Tesla, would be my guess, yes,&#8221; Musk has said.
Musk has also been <a href="https://www.benzinga.com/news/24/11/41766808/mark-cuban-congratulates-trump-musk-before-the-election-is-called-says-they-won-fair-and-square">an active political backer</a> for Trump's 2024 campaign, reportedly donating over $130 million to support his re-election efforts.
Trump&#8217;s victory speech didn't shy away from showing gratitude either. 
As Forbes highlighted, Trump took nearly 4 minutes in his first speech to praise Musk, calling him a "super genius" and highlighting Tesla's achievements, from SpaceX's rocket launches to the expanding satellite internet network.
"A star is born — Elon!" Trump declared.
Musk has expressed enthusiasm about heading a proposed Department of Government Efficiency (D.O.G.E.), where he'd lead efforts to trim wasteful spending from the federal budget. Trump touted Musk as the ideal candidate to serve as the "Secretary of Cost-Cutting," potentially overseeing an ambitious plan to slash $2 trillion in federal expenses.
<h3 class="wp-block-heading">Musk&#8217;s Wealth Outpaces 475 S&amp;P 500 Companies</h3>
To put his wealth into perspective, Musk could theoretically buy out companies in the S&amp;P 500 with valuations smaller than his own, a list as big as 474 names.
Major corporations like Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>), valued at $287 billion, and The Coca-Cola Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) at $276 billion, are now "within reach" for Musk's personal fortune.
With $305 billion, Musk could also theoretically acquire three companies in the $100 billion range, like Prologis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLD#NYSE">PLD</a>), Deere &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>) and Lam Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), with cash to spare.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/sector-etfs/24/11/41853824/sp-500-breaks-6000-points-dow-soars-above-44000-small-caps-eye-strongest-week-in-4-years-tesla-hits-1-trillion-whats-driving-markets-friday">S&amp;P 500 Breaks 6,000 Points, Dow Soars Above 44,000, Small Caps Eye Strongest Week In 4 Years, Tesla Hits $1 Trillion: What&#8217;s Driving Markets Friday?</a></li>
</ul>

Large Cap

Management

Tech

LRCX

Elon Musk's Wealth Tops $300 Billion As Tesla's Market Cap Soars Above $1 Trillion

argenx: Myositis Data Could Add Billions In Value

Leerink Partners analyst Thomas Smith has maintained their bullish stance on IMVT stock, giving a Buy rating yesterday. Thomas Smith has given his ...

Buy Rating Backed by Promising Batoclimab Results for Graves' Disease Treatment

H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Immunovant (IMVT – Research Report) today and set a price target of $51.00. Douglas...

Buy Rating for Immunovant: A New Hope in Graves' Disease Treatment

Immunovant: Switching Lead Candidates Increases Risk

Sam Slutsky, an analyst from LifeSci Capital, maintained the Buy rating on Immunovant (IMVT – Research Report). The associated price target remains...

Immunovant's Promising Advances in GD Treatment and Strong Financial Position Bolster Positive Outlook

In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Immunovant (IMVT – Research Report), with a price target of...

Promising Phase 2a Results for Immunovant's Batoclimab Support Buy Rating

As of September 30, Immunovant's (IMVT) cash and cash equivalents totaled approximately $472.9M. "Since announcing the Phase 1 data for IMVT-1402 a...

Immunovant reports Q3 EPS (74c), consensus (60c)

Stifel raised the firm's price target on Immunovant (IMVT) to $58 from $52 and keeps a Buy rating on the shares after the company's Q2 update. The ...

Immunovant price target raised to $58 from $52 at Stifel

Jason Gerberry, an analyst from Bank of America Securities, reiterated the Buy rating on Immunovant (IMVT – Research Report). The associated price ...

Promising Potential in Immunovant's FcRn Program: Buy Rating on Advancements in Rheumatoid Arthritis and Strategic Trial Design

ARGX

IMVT

Press Releases

Immunovant to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Earnings

Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended December 31, 2023

Immunovant Awarded U.S. Patent for IMVT-1402

Health Care

Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024

Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2024

Immunovant to Host Graves' Disease Program Update on September 9, 2024

Immunovant Provides Update on Graves' Disease Development Program

Ankyra Announces Appointment of Dr. Julia Butchko and Ms. Tara Withington to the Board of Directors

Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves' Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting

Comments

Immunovant

Notizie

Ultime notizie per Immunovant (NASDAQ:IMVT) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO